Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Colorcon
McKesson
Medtronic
Mallinckrodt

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Almorexant

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Almorexant?

Almorexant is an investigational drug.

There have been 7 clinical trials for Almorexant. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2008.

The most common disease conditions in clinical trials are Sleep Initiation and Maintenance Disorders, Restless Legs Syndrome, and Psychomotor Agitation. The leading clinical trial sponsors are Midnight Pharma, LLC, Northern California Institute of Research and Education, and U.S. Army Medical Research and Materiel Command.

Recent Clinical Trials for Almorexant
TitleSponsorPhase
Treatment of Restless Legs Syndrome With the Hypocretin Antagonist SuvorexantDiego Garcia-Borreguero, Paseo de la Habana 151, Madrid 28036, SPAINPhase 2
Treatment of Restless Legs Syndrome With the Hypocretin Antagonist SuvorexantRocío Prieto PérezPhase 2
Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-462206ActelionPhase 1

See all Almorexant clinical trials

Clinical Trial Summary for Almorexant

Top disease conditions for Almorexant
Top clinical trial sponsors for Almorexant

See all Almorexant clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Baxter
McKinsey
Moodys
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.